Idorsia
(OTC) IDRSF
Idorsia Financials at a Glance
Market Cap
$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CHF 219.10M
Net Income (TTM)
-CHF 221.11M
EPS (TTM)
-$1.19
P/E Ratio
-6.73
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$8.00
Volume
2,500
Open
$8.00
Price
$8.00
Volume
2,500
Open
$8.00
Previous Close
$8.00
Daily Range
$8.00 - $8.00
52-Week Range
$3.00 - $8.00
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
-0.01 (Low)
Price
$8.00
Volume
2,500
Open
$8.00
Previous Close
$8.00
Daily Range
$8.00 - $8.00
52-Week Range
$3.00 - $8.00
Estimated Earnings Date
Jul 30, 2026
IDRSF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Idorsia
Industry
Biotechnology
Sector
Health CareEmployees
487
CEO
Jean-Paul Clozel, MD
Website
www.idorsia.comHeadquarters
Allschwil, BL 4123, CH
IDRSF Financials
Key Financial Metrics (TTM)
Gross Margin
87.88%
Operating Margin
-95.64%
Net Income Margin
-100.74%
Return on Equity
19.23%
Return on Capital
-89.54%
Return on Assets
-45.95%
Earnings Yield
-14.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
263.06M
Volume
2.50K
Avg. Volume
3.53K
Financials (TTM)
Gross Profit
CHF 188.37M
Operating Income
-CHF 125.47M
EBITDA
-CHF 143.64M
Operating Cash Flow
-CHF 125.92M
Capital Expenditure
-CHF 14.38M
Free Cash Flow
-CHF 140.30M
Cash & ST Invst.
CHF 94.70M
Total Debt
CHF 1.32B
Idorsia Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CHF 57.39M
-2.5%
Gross Profit
CHF 49.33M
-12.6%
Gross Margin
85.95%
N/A
Market Cap
$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.91M
N/A
Employees
1,100
N/A
Net Income
-CHF 45.70M
-172.4%
EBITDA
-CHF 22.77M
-130.2%
Quarterly Fundamentals
Total Cash
CHF 94.70M
+46.0%
Total Debt
CHF 1.32B
+5.3%
Accounts Receivable
CHF 55.26M
+62.9%
Inventory
CHF 78.30M
+25.3%
Long Term Debt
CHF 1.31B
+25.6%
Short Term Debt
CHF 22.69M
-89.1%
Return on Assets
-45.95%
N/A
Return on Invested Capital
-63.36%
N/A
Free Cash Flow
-CHF 28.25M
+53.6%
Operating Cash Flow
-CHF 26.63M
+56.1%